Premium
SSRI use in late pregnancy increases risk of internalizing disorders in preschool offspring, no risk to development
Publication year - 2018
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30281
Subject(s) - offspring , pregnancy , confounding , prenatal exposure , psychology , psychiatry , child development , developmental psychology , medicine , clinical psychology , genetics , biology
Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) has no substantial increased risk on children's behavioral, emotional, and social development, according to a study that followed mother‐child dyads from pregnancy through age 5 of the child. There was a risk for great anxious/depressed behaviors in the children when the SSRI was taken during late pregnancy only, but unmeasured confounding can't be ruled out, the researchers concluded.